BridgeMD
New treatment option for Renal Insufficiency, Chronic
Official title Multi-parametric MRI Evaluation of Renal Graft Performance After Living Donor Donation.
ClinicalTrials.gov ID: NCT06047106
What this study is testing
What is blood samples?
blood samples is an investigational medicine, being studied as a potential treatment for renal insufficiency, chronic.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The selection of kidneys from living donors is based on strict glomerular filtration rate (GFR) values, in the setting of the increasing proportion of older donors. The 2017 KDIGO recommendations consider that approving kidney donation for a donor with a GFR between 60 and 89 mL/min/1.73 m² should be individually discussed, possibly using a calculator.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- For recipients:
- Patients with end-stage chronic kidney disease awaiting kidney transplant from a living donor.
- Adult patient
- Consent signed
- effective contraceptive method for women
You likely can't join if
- For the two groups :
- MRI contraindications (claustrophobia, pacemaker, cardioverter defibrillators implantable, mechanical heart valve non MRI-compatible)
- Weight\> 130 kg
- Pregnant, parturient or breastfeeding
- Persons deprived of their liberty by a judicial or administrative decision,
- Adults subject to a legal protection measure (safeguard measure, guardianship, curators)
See the full eligibility criteria
- For recipients:
- Patients with end-stage chronic kidney disease awaiting kidney transplant from a living donor.
- Adult patient
- Consent signed
- effective contraceptive method for women
- Patient affiliated to a social security or beneficiaries of a similar scheme For donors:
- Individuals eligible for living kidney donation with GFR \> 60 mL/min/1.73 m².
- Adult patient
- Consent signed
- effective contraceptive method for women
- Patient affiliated to a social security or beneficiaries of a similar scheme
- For the two groups :
- MRI contraindications (claustrophobia, pacemaker, cardioverter defibrillators implantable, mechanical heart valve non MRI-compatible)
- Weight\> 130 kg
- Pregnant, parturient or breastfeeding
- Persons deprived of their liberty by a judicial or administrative decision,
- Adults subject to a legal protection measure (safeguard measure, guardianship, curators)
- subject participating in another research including an exclusion period still in progress at inclusion For recipients : \- Contraindication to renal graft biopsy (ongoing or uninterrupted anticoagulant or antiplatelet...
The study team makes the final eligibility decision.
Where it's taking place
- Lyon, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Lyon, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.